Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

New UK body to fast-track breakthrough research

December 8, 2006 Research and Development

Faster approval of NHS clinical trials and NICE recommendations are almost certain following a fundamental shake-up in the way UK …
News

Novartis readies Prexige for European launch

December 8, 2006 Research and Development, Sales and Marketing

Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …
News

Get the best from your R&D team

December 6, 2006 Business Services, Research and Development R&D, recruitment

One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …
Feature

Cholesterol drug failure hits Pfizer

December 4, 2006 Research and Development, Sales and Marketing

Pfizer has suffered a major blow with its decision to cancel late-stage pipeline torcetrapib following safety concerns.Torcetrapib, which raises 'good' …
News

Takeover will create UK leader in pulmonary products

November 29, 2006 Research and Development, Sales and Marketing

Pulmonary product development in the UK has received a boost following the takeover by biotech company Vectura of the drug …
News

Merck looks to traditional medicine in cancer research

November 20, 2006 Research and Development

Merck is to collaborate with traditional medicine company Chi-Med to develop new small molecule anti-cancer drugs from natural products.Chi-Med, based …
News

Sanofi-Aventis to collaborate with French biotech company on Alzheimer’s disease

November 20, 2006 Research and Development

Pharma company Sanofi-Aventis has entered into a research agreement with a major French biotech firm to study the role of …
News

Future global R&D for Bayer Schering defined

November 17, 2006 Research and Development

Following the merger deal between German pharma companies Bayer and Schering earlier this year, the new corporation has unveiled radical …
News

UK biotech comes to market

November 10, 2006 Research and Development biotech, investment

At last, the signals are getting stronger that the biotechnology industry is poised and ready to tackle the publicly quoted …
Feature

Sepsis drug put back at least two years

November 9, 2006 Research and Development

 AstraZeneca is being forced to conduct a second phase II trial on its sepsis drug, CytoFab.This follows discussions with US, …
News

‘Pulsed’ vitamin D drug could transform advanced prostate cancer treatment

November 9, 2006 Research and Development

American biotech company Novacea says it could be on the brink of revolutionising the prostate cancer market if phase III …
News

Novartis to be first pharma to conduct R&D in China

November 7, 2006 Research and Development Asia, China, Novartis, em

Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …
News

New clinical trials agreement to improve UK research

November 3, 2006 Research and Development

The Department of Health has revised its routine contract for industry-funded NHS clinical trials as a way of improving their …
News

GSK suffers pipeline setbacks

November 1, 2006 Research and Development

 A series of problems with GlaxoSmithKline's late stage product pipeline has taken the shine off its third quarter figures.The company …
News

Pharma’s evolving relationship with NICE

November 1, 2006 Research and Development, Sales and Marketing NHS, NICE, approval process, fast track, healthcare

Back when New Labour was only halfway through its first term of office and when the Millennium Bug was feared …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025